4-Chloro-1-(4-methoxybenzyl)-1H-imidazo[4,5-c]pyridine-2(3H)-thione, 95+%, 5g

[2,4-Difluoro-3-(trifluoromethyl)phenyl]boronic acid, 98%, 1g

{1-AZABICYCLO[2.2.2]OCTAN-4-YLMETHANOL, 95%, 500mg

Dialysis membrane Spectra/Por® 1 to 4 Spectra/Por® 4 - MWCO 12,000 to 14,000, 75 mm, 15 m, 1 Piece(s)

8-ethyl-4-[2-(trifluoromethyl)benzoyl]-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

1-(Diphenylmethyl)-3-hydroxyazetidine, 97.0%, 1kg

4-METHYL-5-(TRIFLUOROMETHYL)-1H-PYRAZOL-3-AMINE, 95.0%, 250mg

2-(chloromethyl)-5-(3-fluorophenyl)-1,3,4-oxadiazole, 95.0%, 5g

DI-TERT-BUTYL 1-(BICYCLO[1.1.1]PENTAN-1-YL)HYDRAZINE-1,2-DICARBOXYLATE, 95.0%, 1g

2-[4-(2-Dimethylamino-5-trifluoromethyl-pyridin-3-yl)-phenoxy]-propionic acid, 95.0%, 500mg

2-Iodo-2-methylpropane (stabilized with Copper chip)>97.0%(GC)25g

3,4-(Methylenedioxy)phenylmagnesium bromide, 0.5M THF, 97.0%, 100ml

tert-Butyl (9-hydroxynonyl)carbamate, 95%, 100mg